LSD And Magic Mushroom’s Active Compound Appear To Have The Same Effects, New Study Finds
A new peer-reviewed study compared the effects of LSD and psilocybin, two substances currently standing as top molecules…
MindMed Announces Publication Of Study Comparing The Acute Effects Of Lysergic Acid Diethylamide And Psilocybin In Healthy Subjects
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (NEO: MMED), a clinical-stage biopharmaceutical company developing psychedelic-inspired therapies for the treatment of brain-based disorders, today announced the peer-reviewed
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS:
Field Trip Health (NASDAQ:FTRP) shares closed up 8.16% at $1.59
Psychedelic Stock Gainers And Losers From February 22, 2022
GAINERS:
LOSERS:
Mindset Pharma (OTC:MSSTF) shares closed down 12.73% at $0.48
Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education
Psychedelics-focused biotech company Cybin Inc. (NYSE: CYBN) announced that it has formed a partnership with The Chopra Foundation, a not-for-profit founded by alternative medicine and new age author Deepak Chopra.
Psychedelic Stock Gainers And Losers From February 15, 2022
GAINERS:
Mind Medicine (NASDAQ:MNMD) shares closed up 10.74% at $1.34
Psychedelic Stock Gainers And Losers From February 14, 2022
GAINERS:
Wellbeing Digital (OTC:KONEF) shares closed up 145.45% at $0.54
Mind Medicine, Cybin Among Top Psychedelic Movers Of Today
GAINERS:
Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22
LOSERS:
Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25
Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05
ATAI Life SciencesGAINERS:
Psychedelic Stock Gainers And Losers From February 9, 2022
GAINERS:
ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76